Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Valneva Se ADR (NQ: VALN )

11.62 +0.22 (+1.93%)
Streaming Delayed Price Updated: 11:26 AM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Valneva Se ADR

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®
From VBI Vaccines Inc.
Via Business Wire
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
From Pfizer Inc.
Via Business Wire
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
From Pfizer Inc.
Via Business Wire
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
From Pfizer Inc.
Via Business Wire
NASDAQ:VALN Shareholder Notice: Investigation Concerning Possible Wrongdoing at Valneva SE
San Diego, CA -- (SBWIRE) -- 11/08/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Valneva SE. 
Via SBWire
Exposures COVID-19
NASDAQ:VALN Investor Notice: Investigation over Potential Securities Laws Violations by Valneva SE
San Diego, CA -- (SBWIRE) -- 09/27/2021 -- Valneva SE is under investigation over possible securities laws violations by in connection with certain financial statements. 
Via SBWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.